Skip to main content
. 2020 Jan 22;34(6):e23217. doi: 10.1002/jcla.23217

Table 5.

Predominance of aβ2GPI‐IgA in our previous studies

Authors Autoimmune diseases aβ2GPl‐IgG (%) aβ2GPl‐IgA (%) aβ2GPl‐IgM (%)
Mankaï et al16 Celiac disease 1.6 14.3 1.6
Mankaï et al17 Systemic lupus erythematosus 19.8 50.9
Mankaï et al13 Primary biliary cholangitis 12.5 62.5 21.2
Mankaï et al18 Antiphospholipid syndrome 22 83.1
Present study Rheumatoid arthritis 6.7 26.7 5.6